Our 145% Profit in Medifast

Last week, I noted that Medifast (MED) reported blow-out earnings. The stock has rallied strongly ever since and it shows no signs of slowing down. The shares are already up 18% in November. Since I first added the stock to the Emerging Growth Buy List, it’s gained 145%! Medifast continues to be an outstanding buy.

More Louis Navellier

Twitter

Facebook

RSS Feed

Little Book

InvestorPlace Network

InvestorPlace.com